| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72162-2134-1 | 72162-2134 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20230920 | N/A | ANDA | ANDA212875 | Bryant Ranch Prepack | CHLORTHALIDONE | 50 mg/1 | 100 TABLET in 1 BOTTLE (72162-2134-1) |
| 72162-2134-3 | 72162-2134 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20230920 | N/A | ANDA | ANDA212875 | Bryant Ranch Prepack | CHLORTHALIDONE | 50 mg/1 | 30 TABLET in 1 BOTTLE (72162-2134-3) |
| 72162-2134-6 | 72162-2134 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20230920 | N/A | ANDA | ANDA212875 | Bryant Ranch Prepack | CHLORTHALIDONE | 50 mg/1 | 60 TABLET in 1 BOTTLE (72162-2134-6) |
| 51224-118-50 | 51224-118 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220805 | N/A | ANDA | ANDA212875 | TAGI Pharma, Inc. | CHLORTHALIDONE | 50 mg/1 | 100 TABLET in 1 BOTTLE (51224-118-50) |
| 51224-118-70 | 51224-118 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220805 | N/A | ANDA | ANDA212875 | TAGI Pharma, Inc. | CHLORTHALIDONE | 50 mg/1 | 1000 TABLET in 1 BOTTLE (51224-118-70) |